Publications en collaboration avec des chercheurs de Centro de Investigación Cooperativa en Biomateriales (4)

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

2018

  1. HIV transgene expression impairs K+ channel function in the pulmonary vasculature

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 315, Núm. 5, pp. L711-L723

  2. Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

    Scientific Reports, Vol. 8, Núm. 1